Rozing J - Search Results

1

Intrathymic immune modulation prevents acute rejection but not the development of graft arteriosclerosis (chronic rejection).

Hillebrands JL, Raué HP, Klatter FA, Hylkema MN, Platteel I, Hardonk-Wubbena A, Nieuwenhuis P, Rozing J. Hillebrands JL, et al. Among authors: rozing j. Transplantation. 2001 Apr 15;71(7):914-24. doi: 10.1097/00007890-200104150-00017. Transplantation. 2001. PMID: 11349727

2

Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis.

Hillebrands JL, Klatter FA, Rozing J. Hillebrands JL, et al. Among authors: rozing j. Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):380-7. doi: 10.1161/01.ATV.0000059337.60393.64. Epub 2003 Jan 30. Arterioscler Thromb Vasc Biol. 2003. PMID: 12615698

3

Cytomegalovirus-enhanced development of transplant arteriosclerosis in the rat; effect of timing of infection and recipient responsiveness.

Hillebrands JL, van Dam JG, Onuta G, Klatter FA, Grauls G, Bruggeman CA, Rozing J. Hillebrands JL, et al. Among authors: rozing j. Transpl Int. 2005 Jun;18(6):735-42. doi: 10.1111/j.1432-2277.2005.00139.x. Transpl Int. 2005. PMID: 15910303 Free article.

4

Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.

Onuta G, Rienstra H, de Boer JF, Boer MW, Roks AJ, Klatter FA, Uges DR, Navis G, Rozing J, Hillebrands JL. Onuta G, et al. Among authors: rozing j. Transplantation. 2007 Aug 27;84(4):517-26. doi: 10.1097/01.tp.0000276983.91892.99. Transplantation. 2007. PMID: 17713437

5

Dichotomous effects of rosiglitazone in transplantation-induced systemic vasodilator dysfunction in rats.

Onuta G, Hillebrands JL, Rienstra H, Boer MW, Klatter FA, Navis G, Rozing J, Roks AJ. Onuta G, et al. Among authors: rozing j. Transplantation. 2008 Feb 27;85(4):582-8. doi: 10.1097/TP.0b013e3181639c83. Transplantation. 2008. PMID: 18347538

6

An alternative model to study intrathymic tolerance induction: the neonatal heart-in-ear transplantation model in the rat.

Hillebrands JL, Klatter FA, Raué HP, Koops RA, Hylkema MN, Rozing J. Hillebrands JL, et al. Among authors: rozing j. Transplant Proc. 1999 May;31(3):1563-6. doi: 10.1016/s0041-1345(99)00038-x. Transplant Proc. 1999. PMID: 10331002 No abstract available.

7

Chronic allograft rejection associated vasculopathy and synthetic biodegradable vascular grafts: a lesson to learn?

Nieuwenhuis P, Hillebrands JL, Rozing J. Nieuwenhuis P, et al. Among authors: rozing j. Crit Rev Immunol. 2000;20(1):85-8. Crit Rev Immunol. 2000. PMID: 10770271 Review.

8

Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis.

Hillebrands J, van den Hurk BM, Klatter FA, Popa ER, Nieuwenhuis P, Rozing J. Hillebrands J, et al. Among authors: rozing j. J Heart Lung Transplant. 2000 Dec;19(12):1183-92. doi: 10.1016/s1053-2498(00)00209-6. J Heart Lung Transplant. 2000. PMID: 11124488

9

Development of transplant arteriosclerosis after allogeneic aorta transplantation in the rat: influence of recipient genotype.

Hillebrands JL, Klatter FA, Bruggeman CA, Rozing J. Hillebrands JL, et al. Among authors: rozing j. Transplant Proc. 2001 Feb-Mar;33(1-2):324-5. doi: 10.1016/s0041-1345(00)02031-5. Transplant Proc. 2001. PMID: 11266843 No abstract available.

10

Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.

Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, Rozing J. Hillebrands JL, et al. Among authors: rozing j. J Clin Invest. 2001 Jun;107(11):1411-22. doi: 10.1172/JCI10233. J Clin Invest. 2001. PMID: 11390423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters